These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Clinical effect and mechanism of action in the continuous oral therapy using microdosis of chlormadinone acetate for the control of human fertility]. Zañartu J; Rodriguez-Moore G; Pupkin M; Rosenberg D; Davansens A; Guerrero R; Rodriguez-Bravo R; Garcia-Huidobro M; Puga JA Rev Med Chil; 1968 Nov; 96(11):739-46. PubMed ID: 4180031 [No Abstract] [Full Text] [Related]
4. Sequential mestranol-chlormadinone acetate as an oral contraceptive. Tyler ET Obstet Gynecol; 1966 Dec; 28(6):787-92. PubMed ID: 4162518 [No Abstract] [Full Text] [Related]
5. Cooperative studies of sequens, a sequential oral contraceptive agent, in Japan. Sawasaki C; Ashitaka Y J Jpn Obstet Gynecol Soc; 1968 Apr; 15(2):96-107. PubMed ID: 4175084 [No Abstract] [Full Text] [Related]
6. Our experience with sequential estrogen-progestin treatments to inhibit ovulation. Cittadini E; Quartararo P; Romano F Int J Fertil; 1969; 14(2):180-7. PubMed ID: 4181574 [No Abstract] [Full Text] [Related]
7. [Clinical experiences with a new ovulation repressor]. Block E Lakartidningen; 1968 May; 65(21):2152-3. PubMed ID: 4177742 [No Abstract] [Full Text] [Related]
8. [Clinical evaluation of Madinon-s, an oral contraceptive]. Borenstein R; Lancet M; Hurwitz N Harefuah; 1970 Jul; 79(1):8-11. PubMed ID: 4099993 [No Abstract] [Full Text] [Related]
9. [Advantage of the use of an estroprogestational drug: 3 mg of chlormadinone acetate + 100 mcg of mestranol in endocrine gynecology]. Bernard I Bord Med; 1970; 3(7):1954-60. PubMed ID: 4195405 [No Abstract] [Full Text] [Related]
13. Chlormadinone acetate 0-5 mg. A report on its effectiveness in continuous use as an oral contraceptive. Christie GA Med J Aust; 1969 Jul; 2(4):185-9. PubMed ID: 4184973 [No Abstract] [Full Text] [Related]
15. [Provisional results of a clinical study of sequential and combination therapy with oral contraceptives]. Arnold M; Angst-Horridge A; Burckhardt-Tamm E; Cloeren S; Mall-Haefeli M; Richter RH; Streit-Pfenniger M; Wyss H Gynaecologia; 1968; 165(2):218-20. PubMed ID: 4178566 [No Abstract] [Full Text] [Related]
16. The effect of the oral contraceptive Ovosiston on the composition of human milk. Ramadan MA; Salah MM; Eid SZ; Sammour MB J Reprod Med; 1972 Aug; 9(2):81-3. PubMed ID: 4115112 [No Abstract] [Full Text] [Related]
17. [Lactation inhibition with chlormadinone and mestranol]. Pilawski Z; Olszewska D; Piernikowski Z; Pronicki B Wiad Lek; 1973 Feb; 26(3):203-7. PubMed ID: 4120298 [No Abstract] [Full Text] [Related]
18. [Enzymatic and electrophoretic serum examination in long term therapy with the oral contraceptive Ovosiston]. Canzler E; Schlegel L Dtsch Gesundheitsw; 1969 Mar; 24(8):367-71. PubMed ID: 4193401 [No Abstract] [Full Text] [Related]